Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration
about
Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration
description
clinical trial
@en
klinisch onderzoek
@nl
name
Post-authorization Safety Stud ...... ume Depletion, and Dehydration
@en
type
label
Post-authorization Safety Stud ...... ume Depletion, and Dehydration
@en
prefLabel
Post-authorization Safety Stud ...... ume Depletion, and Dehydration
@en
P1050
P1132
P1476
Post-authorization Safety Stud ...... P-4 Inhibitors in Saudi Arabia
@en
P3098
NCT03764631
P580
2018-09-27T00:00:00Z
P582
2020-06-30T00:00:00Z